Supplementary PLS from Randomized Trial of Tepotinib Plus Gefitinib Versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

Autor:	Yi-Long Wu, Andreas Johne, Rolf Bruns, Karin Berghoff, Jun Zhao, Yiping Zhang, James Chih-Hsin Yang, Sang Won Shin, Shun Lu, Ying Cheng, Ross Andrew Soo, Dong-Wan Kim, Jianying Zhou, Te-Chun Hsia, Azura Rozila Ahmad, Chong Kin Liam
Rok vydání:	2023
Popis:	Plain language summary
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::502e98744f28781160442e0abf336405 https://doi.org/10.1158/1078-0432.22665304 Zobrazit plný text záznamu